Last 745.45 INR
Change Today +1.75 / 0.24%
Volume 104.6K
TRP On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

torrent pharmaceuticals ltd (TRP) Snapshot

Open
735.05
Previous Close
743.70
Day High
761.50
Day Low
725.00
52 Week High
07/31/14 - 785.00
52 Week Low
08/22/13 - 384.90
Market Cap
126.1B
Average Volume 10 Days
117.2K
EPS TTM
39.23
Shares Outstanding
169.2M
EX-Date
06/16/14
P/E TM
19.0x
Dividend
10.00
Dividend Yield
1.34%
Current Stock Chart for TORRENT PHARMACEUTICALS LTD (TRP)

Related News

No related news articles were found.

torrent pharmaceuticals ltd (TRP) Related Businessweek News

No Related Businessweek News Found

torrent pharmaceuticals ltd (TRP) Details

Torrent Pharmaceuticals Limited, together with its subsidiaries, manufactures and sells branded and unbranded generic pharmaceutical products in India and internationally. The company offers its products in therapeutic areas of cardiovascular, central nervous system, gastrointestinal, anti-infective, diabetology, and pain management areas. It offers products in the form of tablets, capsules, and parenterals. The company’s active pharmaceutical ingredients comprise nicorandil, risperidone, venlafaxine hydrochloride, ropinarole hydrochloride, duloxetine hydrochloride, ormeloxifen hydrochloride, nebivolol hydrochloride, lamotrigine, sertraline hydrochloride, and clopidogrel bisulphate, as well as atomoxatine hydrochloride, rivastigmine hydrogen tartrate, and esomeprazole sodium. It also provides contract manufacturing services primarily for human insulin. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. Torrent Pharmaceuticals Limited was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Private Limited.

9,540 Employees
Last Reported Date: 07/2/14
Founded in 1959

torrent pharmaceuticals ltd (TRP) Top Compensated Officers

Executive Vice Chairman, Managing Director, M...
Total Annual Compensation: 313.0K
Director of Research & Development, Whole-Tim...
Total Annual Compensation: 27.4M
Compensation as of Fiscal Year 2014.

torrent pharmaceuticals ltd (TRP) Key Developments

Torrent Pharmaceuticals Ltd. Reports Audited Standalone and Unaudited Consolidated Earnings Results for the First Quarter Ended June 30, 2014

Torrent Pharmaceuticals Ltd. reported audited standalone and unaudited consolidated earnings results for the first quarter ended June 30, 2014. For the quarter, on standalone basis, the company reported net sales /income from operations was INR 8,960 million compared to INR 8,180 million a year ago. Profit from operations before other income finance cost and exceptional items was INR 3,550 million compared to INR 2,680 million a year ago. Profit from ordinary activities before tax was INR 3,870 million against INR 2,740 million a year ago. Net profit was INR 3,050 million or INR 18.01 per basic and diluted share compared to net profit of INR 2,140 million or INR 12.64 per basic and diluted share a year ago. For the quarter, on consolidated basis, the company reported net sales /income from operations was INR 10,920 million compared to INR 9,030 million a year ago. Profit from operations before other income and finance cost was INR 3,240 million compared to INR 1,870 million a year ago. Profit from ordinary activities before tax was INR 3,490 million against INR 1,870 million a year ago. Net profit was INR 2,560 million or INR 15.12 per basic and diluted share compared to net profit of INR 1,490 million or INR 8.81 per basic and diluted share a year ago. Revenue was INR 11,140 million compared to INR 9,720 million a year ago. EBITDA was INR 3,450 million compared to INR 2,080 million a year ago.

Torrent Pharmaceuticals Ltd. Declares Interim Dividend and Declaration of Special Dividend for the Financial Year Ended March 31, 2014

Torrent Pharmaceuticals Ltd. declared payment of interim dividend of INR 5.00 per equity share as normal annual dividend and declaration of special dividend of INR 5.00 per equity share as final dividend of fully paid up face value of INR 5.00 each for the financial year ended March 31, 2014.

Torrent Pharmaceuticals Ltd. to Report Q1, 2015 Results on Jul 30, 2014

Torrent Pharmaceuticals Ltd. announced that they will report Q1, 2015 results on Jul 30, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRP:IN 745.45 INR +1.75

TRP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Divi's Laboratories Ltd 1,496 INR +20.00
Ipca Laboratories Ltd 724.80 INR +18.35
Jubilant Life Sciences Ltd 190.90 INR +2.90
Piramal Enterprises Ltd 652.05 INR +2.85
Wockhardt Ltd 668.10 INR -3.85
View Industry Companies
 

Industry Analysis

TRP

Industry Average

Valuation TRP Industry Range
Price/Earnings 18.7x
Price/Sales 3.0x
Price/Book 6.5x
Price/Cash Flow 16.6x
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TORRENT PHARMACEUTICALS LTD, please visit www.torrentpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.